ArticleNeoplasia (New York, N.Y.)2008

Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer.

Michael Wy Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.